43 results
Mild-to-Moderate Ulcerative Colitis - Management Algorithm
Curcumin:
 • Natural phytochemical from turmeric
 • 2g/day divided in 2-3
Mild-to-Moderate Ulcerative ... liver disease • 5-ASA ... effective • PO 5-ASA ... when switching 5-ASA ... Waseem_AhmedMD #Ulcerative
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... pubmed.ncbi.nlm.nih.gov/34235889/ AAV ... Treatment #ACR2021 #Guidelines
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
plus aspirin (ASA ... 3 months, but ASA ... 2017 AHA/ACC VHD Guidelines ... 2017 AHA/ACC VHD Guidelines ... Bioprosthetic #Mechanical #Guidelines
Endoscopic Bleeding Risk - Summary points from ASGE guideline 

Low Risk Procedures 
 - Diagnostic endoscopy
points from ASGE guideline ... placement (low if ASA ... Diagnosis #Management #Guidelines
Persistent UC Symptoms Despite 5-ASA Therapies
 • Assess for Drug Adherence
 • Disease Activity Assessment (bloody
Symptoms Despite 5-ASA ... • Optimize 5-ASA ... Waseem_AhmedMD #Ulcerative
Relapsing Acute Severe Ulcerative Colitis - Management Algorithm
Loss of Response:
 • (Re)consult Colorectal Surgery
 • Assess
Relapsing Acute Severe Ulcerative ... Colorectal Surgery ASAP ... Waseem_AhmedMD #Relapsing #Ulcerative
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Management - IDSA Guidelines ... should be removed ASAP ... Candidemia #IDSA #Guidelines
Cardiac Arrest - Guidelines for Crises in Anaesthesia

The probable cause is one or more of: something
Cardiac Arrest - Guidelines ... cause using the guideline ... Council (UK) and ERC Guidelines ... CardiacArrest #Checklist ... Intraoperative #Checklist
Elevated Amylase (Hyperamylasemia)- Differential Diagnosis Algorithm
Pancreatic causes:
 - Pancreatic cancer
 - Complications pancreatitis: eg pseudocyst
 -
obstruction - Drugs: 5-ASA ... celiac disease, ulcerative
JAK Inhibitors in 2019

Role in the therapeutic strategy in 2019
 • RA: 2nd line after failure
biologics • Ulcerative ... after failure of 5-ASA